Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetics

Journal of Internal Medicine

Volumn 244, Issue 1, 1998, Pages 43-48

  Volpi, R ^a   Chiodera, P ^b   Capretti, L ^b   Caffarri, G ^c   Giuliani, N ^d   Caiazza, A ^d   Coiro, V ^d  

^a UNIVERSITY OF PARMA   (Italy)

^b Hospital of Codogno   (Italy)

^c Hospital of Guastalla   (Italy)

^d Fidenza Hospital   (Italy)

Author keywords

C peptide; Diabetes mellitus; Hypoglycaemia; Oxytocin

Indexed keywords

ARGIPRESSIN; C PEPTIDE; GLUCAGON; INSULIN; OXYTOCIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HORMONAL REGULATION; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TOLERANCE TEST; MALE; OXYTOCIN RELEASE; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; GLUCAGON; HUMANS; HYPOGLYCEMIA; INJECTIONS, INTRAVENOUS; INSULIN; MALE; OXYTOCIN;

EID: 0031877671     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00313.x     Document Type: Article

References (38)

1. Würzburger MI, Prevelic GM, Sonksen PH, Balint-Peric LA, Wheeler M. The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes. J Clin Endocrinol Metab 1993; 77: 267-72.
2. Sonksen PH, Russel-Jones D, Jones RH. Growth hormone and diabetes mellitus. Hormone Res 1993; 40: 68-79.
3. Roy MS, Roy A, Gallucci WT, Collser B, Young K, Kamilaris TC et al. The ovine corticotropin-releasing hormone stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism. Metabolism 1995; 42: 697-700.
4. Coiro V, Volpi R, Capretti L, Speroni G, Caffarra P, Scaglioni A et al. Low dose ovine corticotropin releasing stimulation test in diabetes mellitus with and without neuropathy. Metabolism 1995; 44: 538-42.
5. Giustina A, Wehrenberg WB. Growth hormone neuroregulation in diabetes mellitus. TEM 1994; 5: 73-8.
6. Chiodera P, Volpi R, Capretti L, Speroni G, Caffarri G, Colla R et al. Influence of residual C-peptide secretion on the arginine vasopressin response to hypoglycaeinia and metoclopramide in insulin-dependent diabetes. Eur J Clin Invest 1995; 25: 568-73.
7. Iwasaki Y, Kondo K, Murase T, Hasegawa H, Oiso Y, Osmoregulation of plasma vasopressin in diabetes mellitus with sustained hyperglycemia. J Neuroendocrinology 1996; 8: 755-60.
8. Fujisawa I, Murakami N, Furuto-Kato S, Araki N, Konishi J. Plasma and neurohypophyseal content of vasopressin in diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 2805-9.
9. Fischer BM, Baylis PH, Thornton S, Frier BM. Arginine vasopressin and oxytocin responses to insulin-induced hypoglycemia in type I (insulin-dependent) diabetes. J Clin Endocrinol Metab 1989; 68: 688-92.
10. Coiro V, Capretti L, Speroni G, Volpi R, Caiazza A, Rossi G et al. Abnormal arginine-vasopressin responses to metoclopramide and insulin-induced hypoglycemia in type I diabetes mellitus. Hormone Res 1990; 33: 227-32.
11. Baylis PH, Health DA. Plasma vasopressin response to insulin-induced hypoglycaeinia. Lancet 1977; ii: 428-30.
12. Baylis PH, Zerbe RL, Robertson GL. Arginine vasopressin response to insulin-induced hypoglycemia in man. J Clin Endocrinol Metab 1981; 53: 935-40.
13. Fisher BM, Baylis PH, Frier BM. Plasma oxytocin, arginine vasopressin and atrial natriuretic peptide responses to insulin-induced hypoglycaemia in man. Clin Endocrinol 1987; 26: 179-85.
14. Coiro V, Passeri M, Davoli C, d'Amato L, Gelmini G, Fagnoni F et al. Oxytocin response to insulin-induced hypoglycemia in obese subjects before and after weight loss. J Endocrinol Invest 1988; 11: 125-8.
15. Chiodera P, Louis F, Legros JJ. Simultaneous radioimmunoassay for plasma arginine-vasopressin and oxytocin using DEAE Sephadex A-25 extraction. J Endocrinol Invest 1984; 7: 287-93.
16. Koenig RJ, Cerami A. Synthesis of hemaglobin A1c in normal and diabetic mice: potential model of basement membrane thickening. Proc Natl Acad Sci 1975; 72: 3687-791.
17. Koenig RJ, Arajo DC, Cerami A. Increased hemoglobin A1c in diabetic mice. Diabetes 1976; 25: 1-5.
18. Margolis RU, Alzuler N. Insulin in the cerebrospinal fluid. Nature 1967; 215: 1375-6.
19. Woods SC, Porter D, Jr: Relationship between plasma and cerebrospinal fluid insulin levels in dogs. Am J Physiol 1977; 233: 331-4.
20. Honora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V et al. Estimates of in vitro insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 1989; 68: 374-8.
21. Baylis PH. Posterior pituitary function in health and disease. Clin Endocrinol Metab 1983; 12: 747-70.
22. Hems DA, Rodriguez LM, Whitton PD. Rapid stimulation by vasopressin, oxytocin and angiotensin II of glycogen degradation in hepatocyte suspensions. Biochem J 1978; 172: 311-7.
23. Whitton PD, Rodriguez LM, Hems DA. Stimulation by vasopressin, angiotensin and oxytocin of gluconeogenesis in hepatocyte suspensions. Biochem J 1978; 176: 893-8.
24. Chiodera P, Coiro V, Camellini L, Rossi G, Pignatti D, Volpi R et al. Effects of pharmacological doses of oxytocin on insulin response to glucose in normal man. Horm Res 1984; 20: 150-54.
25. Dunning BE, Moltz JH, Fawcett PC. Actions of neurohypophysial peptides on pancreatic hormone release. Am J Physiol 1984; 246: E108-104.
26. Dunning BE, Moltz JH, Fawcett PC. Modulation of insulin and glucagon secretion from rat pancreas by the neurohypophysial hormone and by desamino-D-arginine vasopressin (DDAVP). Peptides 1984; 5: 871-5.
27. Paolisso G, Pizza G, De Riu S, Marrazzo G, Sgambato S, Giugliano D et al. Effects of oxytocin upon the endocrine pancreas secretion and glucose turnover in normal man. Acta Endocrinol 1990; 125: 504-10.
28. Paolisso G, Sgambato S, Passariello N, Mignano S, Torella R, D'Onofrio E. Pharmacological doses of oxytocin affects plasma hormones levels modulating glucose homeostasis in normal man. Horm Res 1988; 30: 10-16.
29. Paolisso G, Sgambato S, Giugliano D, Pizza G, Tesauro P, Varricchio M et al. Effects of oxytocin delivery on counter-regulatory hormone response in insulin-dependent (type I) diabetic subjects. Horm Res 1989; 31: 250-5.
30. Chiodera P, Gnudi A, Bianconi L, Capretti L, Fagnoni F, Volpi R et al. Naloxone abolishes the inhibiting effect of somatostatin on the release of oxytocin evoked by insulin-induced hypoglycemia in humans. Metabolism 1989; 38: 709-11.
31. Chiodera P, Gnudi A, Rossi G, Camellini L, Caiazza A, Marchesi C et al. Dopaminergic, but not cholinergic involvement in regulation of hypoglycemia-induced oxytocin release in man. Psychoneuroendocrinol 1989; 14: 203-8.
32. Djursing H, Carstensen L, Hagen C, Andersen AN. Possible altered dopaminergic modulation of pituitary function in normal menstruating women with insulin-dependent diabetes mellitus (IDDM). Acta Endocrinol 1984; 107: 450-5.
33. Hagen C, Djursing H, Christensen NJ, Andersen AN, Tvede K, Petersen K et al. Abnormal conjugated dopamine levels in patients with normoprolactinaemic amenorrhea and in insulin dependent diabetic patients. Scand J Clin lab Invest 1985; 45: 405-11.
34. Coiro V, Butturini U, Gnudi A, Volpi R, d'Amato L, Speroni G et al. TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration. Hormone Res 1987; 25: 206-14.
35. Coiro V, Volpi R, Capretti L, Colla R, Caffarri G, Vescovi PP et al. Dopaminergic and cholinergic control of arginine-vasopressin secretion in type I diabetic men. Eur J Clin Invest 1995; 25: 412-7.
36. Leidy JW, Cugini CD, Driscoll HK, Chertow BS. Time course of hypothalamic growth hormone-releasing hormone and somatostatin content in streptozotocin diabetic rats: evidence for early changes in hypothalamic regulation. Brain Res 1995; 681: 84-90.
37. Plotsky PM. Hypothalamic secretion of somatostatin and growth hormone-releasing factor into the hypophysial-portal circulation is reduced in streptozotocin-diabetic male rats. Neuroendocrinol 1991; 53: 433-8.
38. Richardson SB, Twente S. Somatostatin release from dispersed hypothalamic cells: effect of diabetes. Diabetologia 1987; 30: 893-8.